Gresonitamab Biosimilar - Anti-CLDN18 &, CD3e mAb - Research Grade, Human Humanized, Monoclonal
Artikelnummer:
PTG-PX-TA1758-100
| Artikelname: |
Gresonitamab Biosimilar - Anti-CLDN18 &, CD3e mAb - Research Grade, Human Humanized, Monoclonal |
| Artikelnummer: |
PTG-PX-TA1758-100 |
| Hersteller Artikelnummer: |
PX-TA1758-100 |
| Alternativnummer: |
PTG-PX-TA1758-100 |
| Hersteller: |
ProteoGenix |
| Wirt: |
Human Humanized |
| Kategorie: |
Antikörper |
| Spezies Reaktivität: |
Human |
| Alternative Synonym: |
Anti-CLDN18.2, Anti-Claudin-18.2, Anti-CD3E, Bispecific, AMG 910, AMG-910, AMG910 CAS: 2413817-97-5 |
| Klonalität: |
Monoclonal |
| UniProt: |
P56856 |
| Puffer: |
0.01M PBS, pH 7.4. |
| Expression System: |
Eukaryotic expression |
| Target-Kategorie: |
CLDN18.2 & CD3E |